International Stem Cell Corporation
Biotechnology, 5950 Priestly Dr, San Diego, California, 92008, United States, 11-50 Employees
Phone Number: 76********
Who is INTERNATIONAL STEM CELL CORPORATION
International Stem Cell Corporation (OTCBB:ISCO) develops a powerful new stem cell technology called parthenogenesis that promises to significantly advance the field of regenerative medic...
Read More
-
Headquarters: 5950 Priestly Dr, San Diego, California, 92008, United States
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 561110 |
Show More
Does something look wrong? Fix it. | View contact records from INTERNATIONAL STEM CELL CORPORATION
International Stem Cell Corporation Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding International Stem Cell Corporation
Answer: International Stem Cell Corporation's headquarters are located at 5950 Priestly Dr, San Diego, California, 92008, United States
Answer: International Stem Cell Corporation's phone number is 76********
Answer: International Stem Cell Corporation's official website is https://intlstemcell.com
Answer: International Stem Cell Corporation's revenue is $10 Million to $25 Million
Answer: International Stem Cell Corporation's SIC: 2834
Answer: International Stem Cell Corporation's NAICS: 561110
Answer: International Stem Cell Corporation has 11-50 employees
Answer: International Stem Cell Corporation is in Biotechnology
Answer: International Stem Cell Corporation contact info: Phone number: 76******** Website: https://intlstemcell.com
Answer: International Stem Cell Corporation (OTCBB:ISCO) develops a powerful new stem cell technology called parthenogenesis that promises to significantly advance the field of regenerative medicine by addressing the significant problem of immune-rejection. Parthenogenesis utilizes unfertilized human eggs to create parthenogenetic stem cells (hpSC) that can be immune-matched to millions of persons of differing sexes and racial backgrounds. A relatively small number of hpSC lines could provide sufficient immune-matched cells to cover large parts of the worlds population. ISCO plans to create a bank of these valuable hpSC lines (UniStemCellTM) to serve all populations across the world. Human parthenogenetic stem cells have great therapeutic potential, yet do not require viable human embryos, thus avoiding ethical issues. ISCOs scientists are focused on using hpSC to treat severe diseases of the eye, the nervous system and the liver where cell therapy has been proven clinically yet is limited by the availability of safe immune-matched human cells. ISCO advances and operates three businesses: Lifeline Cell Technology, Lifeline Skin Care and Universal Stem Cell Bank.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month